Insider Transactions in Q4 2025 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 06
2025
|
Phillip G. Febbo Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
8,349
-8.28%
|
$300,564
$36.02 P/Share
|
|
Oct 01
2025
|
Annie Mc Guire SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
2,160
-2.36%
|
$75,600
$35.0 P/Share
|
|
Oct 01
2025
|
Robert S Epstein Director |
SELL
Open market or private sale
|
Direct |
21,473
-25.59%
|
$751,555
$35.08 P/Share
|
|
Oct 01
2025
|
Robert S Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.65%
|
$70,000
$7.94 P/Share
|
|
Oct 01
2025
|
John Leite Chief Commercial Officer-CLIA |
SELL
Open market or private sale
|
Direct |
2,539
-2.77%
|
$88,865
$35.0 P/Share
|